Cizzle Biotechnology (LON:CIZ) Shares Down 1.3%

Shares of Cizzle Biotechnology Holdings Plc (LON:CIZGet Free Report) fell 1.3% during mid-day trading on Monday . The company traded as low as GBX 1.77 ($0.02) and last traded at GBX 1.85 ($0.02). 6,503,132 shares traded hands during mid-day trading, an increase of 284% from the average session volume of 1,694,328 shares. The stock had previously closed at GBX 1.88 ($0.02).

Cizzle Biotechnology Price Performance

The stock has a market cap of £6.73 million, a price-to-earnings ratio of 185.00 and a beta of 0.40. The firm has a 50 day simple moving average of GBX 2.27 and a two-hundred day simple moving average of GBX 2.18.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Money Concepts Capital Corp bought a new stake in shares of Cizzle Biotechnology during the fourth quarter worth $32,000. UBS Group AG increased its holdings in Cizzle Biotechnology by 20.5% during the 3rd quarter. UBS Group AG now owns 3,395 shares of the company’s stock worth $98,000 after purchasing an additional 578 shares in the last quarter. Atria Wealth Solutions Inc. acquired a new stake in shares of Cizzle Biotechnology in the 1st quarter valued at about $535,000. Jane Street Group LLC acquired a new position in shares of Cizzle Biotechnology during the fourth quarter worth about $716,000. Finally, Royal Bank of Canada lifted its stake in Cizzle Biotechnology by 7.2% in the 1st quarter. Royal Bank of Canada now owns 22,122 shares of the company’s stock valued at $718,000 after acquiring an additional 1,495 shares in the last quarter.

Cizzle Biotechnology Company Profile

(Get Free Report)

Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021.

Recommended Stories

Receive News & Ratings for Cizzle Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cizzle Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.